Growth Metrics

Rigel Pharmaceuticals (RIGL) Assets (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Rigel Pharmaceuticals 551.62 Mn 404.94 Mn 54.21 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1.75%
Dec 31, 2025 111.76%
Sep 30, 2025 17.32%
Jun 30, 2025 17.48%
Mar 31, 2025 7.32%
Dec 31, 2024 17.61%
Sep 30, 2024 8.58%
Jun 30, 2024 1.49%
Mar 31, 2024 7.93%
Dec 31, 2023 1.65%
Sep 30, 2023 -1.51%
Jun 30, 2023 -5.28%
Mar 31, 2023 -7.94%
Dec 31, 2022 16.15%
Sep 30, 2022 -9.68%
Jun 30, 2022 -14.14%
Mar 31, 2022 -10.91%
Dec 31, 2021 -10.29%
Sep 30, 2021 -7.48%
Jun 30, 2021 -6.66%
Mar 31, 2021 95.68%
Dec 31, 2020 -10.30%
Sep 30, 2020 -10.85%
Jun 30, 2020 -3.72%
Mar 31, 2020 -2.85%
Dec 31, 2019 -5.44%
Sep 30, 2019 -0.06%
Jun 30, 2019 -9.62%
Mar 31, 2019 24.21%
Dec 31, 2018 12.94%
Sep 30, 2018 -12.78%
Jun 30, 2018 42.92%
Mar 31, 2018 -17.04%
Dec 31, 2017 67.17%
Sep 30, 2017 -16.65%
Jun 30, 2017 -15.64%
Mar 31, 2017 29.68%
Dec 31, 2016 -11.85%
Sep 30, 2016 -10.75%
Jun 30, 2016 -8.27%
Mar 31, 2016 -17.81%
Dec 31, 2015 -5.33%
Sep 30, 2015 -6.19%
Jun 30, 2015 -10.46%
Mar 31, 2015 7.50%
Dec 31, 2014 -5.57%
Sep 30, 2014 -10.53%
Jun 30, 2014 -10.26%
Mar 31, 2014 -10.07%
Dec 31, 2013 -5.63%
Sep 30, 2013 -8.46%
Jun 30, 2013 -7.52%
Mar 31, 2013 -8.74%
Dec 31, 2012 59.56%
Sep 30, 2012 -9.35%
Jun 30, 2012 -8.36%
Mar 31, 2012 -9.02%
Dec 31, 2011 -6.80%
Sep 30, 2011 -4.83%